(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(((1R,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl)oxy)tetrahydro-2H-pyran-3,4,5-triol; 1,5-Dideoxy-4-O-?-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol; Antibiotic T 7545B;
Validamycin B is a fully characterized chemical compound used as a reference standard of API Validamycin. The standard offered is compliant with regulatory guidelines. Validamycin B is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 102583-47-1
